Drugmaker Claims Stake In La. Mail-Order Abortion Meds Row
By Mark Payne · February 4, 2026, 1:12 PM EST
An abortion medication manufacturer asserted its right Wednesday to defend mifepristone, moving to intervene in a federal lawsuit over mail-order abortion medication brought by Louisiana alleging that regulators violated federal law by...
To view the full article, register now.